NMRA vs NWS · $283.5M cap vs rev $9.03B
Neumora Therapeutics, Inc. (NMRA) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
NWS (NWS) common stock.
NMRA does not have a complete income-statement cache yet.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
NMRA currently screens at market cap $283.5M. NWS currently screens at market cap $0.
Not investment advice. Open the NMRA and NWS stock pages for the full models.
Not investment advice.